Memoria CD.indd - ISHAM

More documents

Recommendations

Info

5-23p 1985-24p 1985-25p 1995-26p 1995-27p 2005-28p 2005-29p 2015-30p 2016-01p 2056-02p 2056-03p 2066-04p 2066-05p 207Nitric oxide but not TREG cells plays a major immunoregulatory role in a pulmonarymodel of fungal infectionBernardino S; Calich VIG.Role of CCR4 in the experimental infection by Paracoccidioides brasiliensis: Migrationcontrol of CD4+CD25+ T cells to lesion siteRocha FA; Oliveira LI; Massafera-Tristão FS; Milanezi CM; Silva JS.Granulomatous inflammation and fibrosis in mice with chronic pulmonary paracoccidioidomycosis:Immune-related associationsNaranjo TW, Lopera DE; Duque JJ; Diaz-Granados LR; Restrepo A; Cano LE.Alterations of granuloma architecture, cellularity and severity of the early infectionin murine paracoccidioidomycosis by IFN-γ, celecoxib or lumiracoxib treatmentMolina RFS; Nishikaku AS; Albe BP; Burger E.Therapeutic activity of a DNA vaccine using the gene Hsp65 from Mycobacteriumleprae for experimental paracoccidioidomycosisRibeiro AM, Souza ACO; Amaral AC; Fraga CIF; Nunes J; Salles BC; Coelho-CasteloAAM; Figueiredo F; Silva CI; Felipe MSS; Bocca AI.Evaluation of the protection induced by the immunization with radioattenuated yeastcells of Paracoccidioides brasiliensis in animal modelMartins EMN, Bernardo S; Reis AMG; Antero SRA.Modulation of experimental paracoccidioidomycosis by monoclonal antibodiesagainst the major diagnostic antigen, Gp43Pinto FA; Puccia R; Da Silva CJ; Muñoz JE; Travassos LR; Taborda CP.The influence of Fonsecaea pedrosoi cell wall in peritoneal macrophage activationNóbrega YKM; Lozano VF; Figueiredo F; Bocca AL.6 TreatmentTiming of itraconazole therapy onset and its impact on the progression of fibrosisinduced by Paracoccidioides brasiliensis conidia: Results in an experimental modelof paracoccidioidomycosisLopera DE; Naranjo TW; Duque DJ; Diaz-Granados LR; Jiménez RA; Restrepo A, ZuluagaAF; Cano LE.Posaconazole for the treatment of paracoccidioidomycosis: First clinical resultsTobón AM; Agudelo CA; Restrepo A.Variable effect of caspofungin on the mycelial and yeastlike phases of several strainsof Paracoccidioides brasiliensisRodríguez-Brito S; Niño-vega G; San-Blas G.Assessment of the efficacy of voriconazole, comparativily to other antifungals, inparacoccidioidomycosis experimental of the ratsGranzoto DS; Vitali LH; Martinez R.Amphotericin B-PLGA-DMSA nanoparticle: A new alternative to treat paracoccidioidomycosisAmaral AC; Bocca AI; Ribeiro AM; Nunes J; Falcomer CI; Peixoto DIG; Simioni AR; Pinto FI;Lacava ZGM; Azevedo RB; Titze-De-Almeida R; Tedesco AC; De Morais PC; Felipe MSS.38
6-06p 2076-07p 2086-08p 2086-09p 2096-10p 2096-11p 2106-12p 2106-13p 211Fungicidal activity of amphotericin B-magnetic fluid conjugate in vitro against ParacoccidioidesbrasiliensisMedeiros PB; Amaral AC, Saldanha CA; Bocca AI; Guilherme RB; Silva JR; Nunes ES;Lima ECD; Azevedo RB; De Morais PC; Felipe MSS.PLGA-P10 conjugate improved 20-times the immunological protection of this peptideagainst Paracoccidioides brasiliensisAmaral AC, Marques AF; Muñoz JE; Bocca AI; Simioni AR; Titze-De-Almeida R; TedescoAC; De Morais PC; Taborda CP; Travassos LR; Felipe MSS.Biological activity of the endophytic fungi UFMGCB551 against ParacoccidioidesbrasiliensisCampos FF; Rosa LH; Johann S; Cota BB; Rosa CA; Sá NP, Cisalpino PS; Zani CI.Antagonistic effect of farnesol, a Candida albicans quorum sensing molecule, onParacoccidioides brasiliensis growth and morphogenesisDerengowski LS; Braz SV; De-Souza-Silva C; Mello-De-Sousa TM; Báo SN; Kyaw CM,Silva-Pereira I..Killing of Paracoccidioides brasiliensis yeast cells by magnetic hyperthermiaAmaral AC; Braun S; Nunes ES; Bocca AI; Lima ECD; Azevedo RB; De Morais PC; FelipeMSS.Antifungal activity of plants extracts used in Brazilian traditional medicine againstParacoccidioides brasiliensisJohann S; Watanabe GA; Cota BB; Siqueira EP; Zani CI; Pizzolatti MG; Cisalpino PS;Resende MA.Treatment of murine paracoccidioidomycosis (PCM) with trimethoprim-sulfamethoxazolecombination (TMP-SMX)Moura F; Lima CRG; Moreto TC; Carvalho LR; Bueno RA; Moris DV; Mendes RP.Therapeutic DNA vaccine in BALB/c and B10A mice against experimental paracoccidioidomycosisGomes-Rittner GM; Muñoz JE; Taborda CP; Travassos LR.6-14p 2116-15p 2127-01p 2157-02p 215Adrenal function in paracoccidioidomycosis patients treated with azolic derivatives:Results after prolonged post-therapy follow upTobón AM; Restrepo CA; Villa CA; Agudelo CA; Quiceno W; Restrepo A..The association tuberculosis-paracoccidioidomycosis: Impact on the outcome oftheraphyTobón AM; Agudelo CA; Tabares AM; Restrepo A.7 Other mycosesSusceptibility to fluconazole and voriconazole of Candida species isolated from intensivecare units patients in several hospitals in Medellín, Colombia (2001 - 2007)Zuluaga A; De Bedout C; Agudelo CA; Hurtado H; Arango M; Restrepo A; González A.Therapeutic study of gomesin in mice infected with Candida albicansRossi DCP; Muñoz JE; Taborda CP ; Daffre S.39
Page 1 and 2: ISSN 0120-4157BiomédicaRevista del
Page 3 and 4: Biomédica Instituto Nacional de Sa
Page 5: Proceedings of theX International C
Page 8 and 9: Financial CommiteeLavive Rebaje de
Page 10 and 11: • Henrique L. Lenzi. Departamento
Page 12 and 13: United States of America• Beatriz
Page 15 and 16: Scholarship WinnersTraveling Award
Page 17 and 18: EditorialIn 1971 the Pan American H
Page 19 and 20: Scientific Program15:00-18:00 Arriv
Page 21 and 22: Symposium 3. Virulence factors and
Page 23 and 24: 16:20-16:4016:40-17:0017:00-17:2017
Page 25 and 26: 14:20-14:4014:40-15:0015:00-15:2015
Page 27 and 28: Symposia IndexPage434344Symposium 1
Page 29 and 30: 91CDC42p controls yeast-cell shape
Page 31 and 32: Poster Index1 Clinical Aspects / Ca
Page 33 and 34: 2-02p 1552-03p 1562-04p 1562-05p 15
Page 35 and 36: 4-20p 1744-21p 1754-22p 1754-23p 17
Page 37: 5-10p 1915-11p 1925-12p 1925-13p 19
Page 41: Symposium1P. brasiliensis:Genomics
Page 44 and 45: Post-genomic contribution to the kn
Page 46 and 47: quence. The first domain (aa 1-1073
Page 49 and 50: Experimental animal models and thei
Page 51 and 52: CD4 + CD25 + FoxP3 + T cells were d
Page 53 and 54: Pattern recognition receptors in th
Page 55: A strategy for the generation of a
Page 59 and 60: Histoplasma virulence mechanisms wi
Page 61 and 62: Virulence insights from the P. bras
Page 63: certain antifungal drugs. The effec
Page 67 and 68: Microbicidal mechanisms exerted by
Page 69 and 70: depletion induces a more severe and
Page 71 and 72: did not restore the lymphoprolifera
Page 73 and 74: Historical accountsCoccidioidomycos
Page 75: In South America, from Venezuela to
Page 79 and 80: B-1 cells modulate the kinetics of
Page 81 and 82: mechanisms can lead to permissivene
Page 83 and 84: of mice (PBS-untreated as negative
Page 85: Symposium6Fungal cellular biology A
Page 88 and 89:
wall construction, mating and osmo-
Page 90 and 91:
heat shock proteins, processes of h
Page 92 and 93:
Differential analysis of extracellu
Page 95 and 96:
The evolving public health importan
Page 97:
Several difficulties have been iden
Page 101 and 102:
The impact of histoplasmosis in HIV
Page 103 and 104:
The conjunct data from 66 cases pre
Page 105 and 106:
Although drug serum levels are an o
Page 107 and 108:
Historical accountsHistoplasmosisHi
Page 109:
Histoplasmosis in the United States
Page 113 and 114:
The value and the promise of molecu
Page 115 and 116:
need to consider the P. brasiliensi
Page 117 and 118:
Lymphomononuclear cells of 29 patie
Page 119:
Symposium10Advances on antifungal A
Page 122 and 123:
and Cryptococcus neoformans. MICs f
Page 124 and 125:
sue assay, revelead that P10-PLGA c
Page 127 and 128:
P. brasiliensis growth and infectiv
Page 129 and 130:
Influence of alternating coffee and
Page 131 and 132:
in Arábica and 0.9% Robusta variet
Page 133:
Symposium12Evolutive Biology of P.
Page 136 and 137:
Is Paracoccidioides brasiliensis an
Page 138 and 139:
matter of conjecture. As a global i
Page 141 and 142:
1-01Clinical epidemiology of paraco
Page 143 and 144:
1-05Epidemiological and clinical fe
Page 145 and 146:
1-09Acute severe paracoccidioidomyc
Page 147 and 148:
1-13Nested-PCR, immunoblotting and
Page 149 and 150:
1-17Scintigraphic evaluation of ent
Page 151 and 152:
1-21Paracoccidioidomycosis in a ren
Page 153:
Poster Session2Diagnosis
Page 156 and 157:
2-03Combined use of Paracoccidioide
Page 159:
Poster Session3Epidemiology / Ecolo
Page 162 and 163:
3-03Spatial distribution of chronic
Page 165 and 166:
4-01Towards a molecular genetic sys
Page 167 and 168:
4-05Evidence for positive selection
Page 169 and 170:
4-09Formamidase of Paracoccidioides
Page 171 and 172:
4-13Mating type genes MAT1-1 and MA
Page 173 and 174:
4-17Autophagy in the human pathogen
Page 175 and 176:
4-21Transcription regulation of the
Page 177 and 178:
4-25Changes in the transcription le
Page 179 and 180:
4-29The high affinity copper transp
Page 181 and 182:
4-33Analysis and identification of
Page 183:
4-37The heath shock factor of Parac
Page 187 and 188:
5-01Phenotypic and functional chara
Page 189 and 190:
5-05Polymorphisms analysis of CTLA-
Page 191 and 192:
5-09Alterations in pulmonary mechan
Page 193 and 194:
5-13The influence of ß2 integrin i
Page 195 and 196:
5-17Prostaglandin inhibits Paracocc
Page 197 and 198:
5-21IL-10 deficiency determines a b
Page 199 and 200:
5-25Granulomatous imflammation and
Page 201:
5-29Modulation of experimental para
Page 205 and 206:
6-01Timing of itraconazole therapy
Page 207 and 208:
6-05Amphotericin B-PLGA-DMSA nanopa
Page 209 and 210:
6-09Antagonistic effect of farnesol
Page 211 and 212:
6-13Therapeutic DNA vaccine in BALB
Page 213:
Poster Session7Other Mycoses
Page 216 and 217:
7-03Study of genotypic and phenotyp
Page 218 and 219:
7-07Detection of DNA in peripheral
Page 220 and 221:
Catão E. 193Cavalcante RS. 103, 14
Page 222 and 223:
Molano VM. 143Molina RFS. 199Montoy
Page 224 and 225:
Trinca LA. 167Tristão FSM. 71Urán
Page 226 and 227:
Personal ContributorsDrs. Karl V. a
show all

Memoria CD.indd - ISHAM

Create successful ePaper yourself

Delete template?

Save as template?